Subretinal fluid resolution in the fellow eye after unilateral aflibercept injection in bilateral neovascular age-related macular degeneration: Coincidence or systemic effect?
R Demirel, S Gültekin Irgat, H I Bike
✦ AI-curated · Sources linked
Case in brief
A 63-year-old woman with bilateral neovascular age-related macular degeneration (nAMD) developed new subretinal fluid (SRF) in her left eye, which had best-corrected visual acuity of 0.8, while receiving treat-and-extend aflibercept therapy in the right eye. To avoid injection-related risks in the better-seeing eye, clinicians treated only the right eye. Three weeks later, optical coherence tomography showed complete resolution of left-eye SRF. The fluid remained absent for 8 weeks before recurring.
What made this case unusual
SRF resolved in the untreated fellow eye after unilateral aflibercept injection, then recurred. The observation raises the possibility of a temporary systemic anti-VEGF effect on fellow-eye choroidal neovascularisation activity.
Diagnostic / clinical pearl
After unilateral anti-VEGF treatment, fellow-eye SRF may resolve temporarily; this single case cannot establish a systemic treatment effect or guide clinical practice.